MASAM Director to Asharq Al-Awsat: Demining Efforts Will Cover All Yemeni Territory

Members of a Yemeni military demining unit prepare to destroy unexploded bombs and mines collected from Aden, Yemen August 2017. (Reuters)
Members of a Yemeni military demining unit prepare to destroy unexploded bombs and mines collected from Aden, Yemen August 2017. (Reuters)
TT

MASAM Director to Asharq Al-Awsat: Demining Efforts Will Cover All Yemeni Territory

Members of a Yemeni military demining unit prepare to destroy unexploded bombs and mines collected from Aden, Yemen August 2017. (Reuters)
Members of a Yemeni military demining unit prepare to destroy unexploded bombs and mines collected from Aden, Yemen August 2017. (Reuters)

Program Manager of the Saudi Project for Landmines Clearance in Yemen (MASAM) Ousama Al-Gosaibi revealed that over 400 specialists have been tasked with ridding Yemen of mines.

He stressed to Asharq Al-Awsat that this humanitarian project aims at clearing mines throughout the country, without discriminating between one region and another.

The 40-million dollar one-year project will be implemented over five phases. It will start with the equipping and training of the personnel, preparing the specialized demining teams, sending them to the field and later relaying their expertise to Yemeni cadres. MASAM is being implemented with Saudi and global expertise, stressed Gosaibi.

Saudi Arabia’s support for Yemen has been one of the Kingdom’s top priorities for decades, he said, underlining the neighborly, religious, social and familial ties that bind the peoples of both countries.

MASAM was funded by the King Salman Humanitarian Aid and Relief Center (KSRelief), which has been offering and continuing to offer humanitarian projects for the war-torn country, he remarked. These efforts have exceeded 1.6 billion dollars.

MASAM seeks to clear the mines that have been arbitrarily planted by the Iran-backed Houthi militias throughout Yemen, most notably in Marib, Aden, Sanaa and Taiz, Gosaibi said. It also seeks to help the Yemeni people overcome the humanitarian tragedy that has resulted from the mines.

Preliminary statistics revealed by Yemeni officials showed that the militias planted nearly one million mines throughout the country.

Gosaibi highlighted in this regard the efforts of the KSRelief-funded prosthetics center in Marib that has so far provided prosthetic limbs to over 195 mine victims, who are often women and children.

MASAM field teams have been in Marib for two months to begin their mine clearance mission. Thirty-two demining teams consisting of over 400 people are operating in Yemen.

He underlined the close cooperation between MASAM and the national Yemeni demining project, saying that each one complements the other.

The Saudi project will focus on sensitive areas that have high populations. It will tackle the provinces of Marib, Aden, Taiz and Sanaa in its first phase, he told Asharq Al-Awsat.

After this phase is complete, MASAM will turn to mines planted in desert regions.

MASAM also boasts rapid intervention experts and others specialized in defusing explosives, Gosaibi said.

The Saudi project, he reiterated, does not discriminate between Yemeni regions. It launched its operations to achieve purely humanitarian goals regardless of the developments in Yemen.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.